REGENXBIO Inc. Shares Outstanding (Cover Page)
REGENXBIO Inc. (RGNX) had Shares Outstanding (Cover Page) of 66.01 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 66.01M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 51.70M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 51.61M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 50.62M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 66.01M shares 10-Q · filed 2026-08-06 |
| 2026-05-08 | 51.70M shares 10-Q · filed 2026-05-14 |
| 2026-02-27 | 51.61M shares 10-K · filed 2026-03-05 |
| 2025-10-31 | 50.62M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 50.51M shares 10-Q · filed 2025-08-07 |
| 2025-05-08 | 50.16M shares 10-Q · filed 2025-05-12 |
| 2025-03-07 | 50.09M shares 10-K · filed 2025-03-13 |
| 2024-10-31 | 49.55M shares 10-Q · filed 2024-11-06 |
| 2024-07-25 | 49.42M shares 10-Q · filed 2024-08-01 |
| 2024-05-02 | 49.26M shares 10-Q · filed 2024-05-08 |
| 2024-02-22 | 44.43M shares 10-K · filed 2024-02-27 |
| 2023-11-02 | 43.99M shares 10-Q · filed 2023-11-08 |
| 2023-07-27 | 43.96M shares 10-Q · filed 2023-08-02 |
| 2023-04-27 | 43.47M shares 10-Q · filed 2023-05-03 |
| 2023-02-23 | 43.46M shares 10-K · filed 2023-02-28 |
| 2022-10-27 | 43.29M shares 10-Q · filed 2022-11-03 |
| 2022-07-27 | 43.23M shares 10-Q · filed 2022-08-03 |
| 2022-04-28 | 43.13M shares 10-Q · filed 2022-05-04 |
| 2021-12-31 | 42.95M shares 10-K · filed 2022-03-01 |
| 2021-10-28 | 42.77M shares 10-Q · filed 2021-11-02 |
| 2021-08-04 | 42.60M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 42.51M shares 10-Q · filed 2021-05-05 |
| 2021-02-25 | 42.50M shares 10-K · filed 2021-03-01 |
| 2020-10-30 | 37.41M shares 10-Q · filed 2020-11-04 |
| 2020-07-31 | 37.33M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 37.24M shares 10-Q · filed 2020-05-07 |
| 2020-02-21 | 37.14M shares 10-K · filed 2020-02-26 |
| 2019-11-01 | 36.87M shares 10-Q · filed 2019-11-05 |
| 2019-08-02 | 36.81M shares 10-Q · filed 2019-08-07 |
| 2019-05-03 | 36.64M shares 10-Q · filed 2019-05-07 |
| 2019-02-22 | 36.42M shares 10-K · filed 2019-02-27 |
| 2018-11-02 | 35.84M shares 10-Q · filed 2018-11-07 |
| 2018-08-03 | 32.31M shares 10-Q · filed 2018-08-08 |
| 2018-05-04 | 31.94M shares 10-Q · filed 2018-05-08 |
| 2018-03-02 | 31.66M shares 10-K · filed 2018-03-06 |
| 2017-11-03 | 31.15M shares 10-Q · filed 2017-11-08 |
| 2017-08-04 | 30.89M shares 10-Q · filed 2017-08-08 |
| 2017-05-05 | 30.82M shares 10-Q · filed 2017-05-09 |
| 2017-03-03 | 26.51M shares 10-K · filed 2017-03-07 |
| 2016-11-04 | 26.48M shares 10-Q · filed 2016-11-09 |
| 2016-08-05 | 26.47M shares 10-Q · filed 2016-08-09 |
| 2016-05-04 | 26.34M shares 10-Q · filed 2016-05-05 |
| 2016-03-01 | 26.33M shares 10-K · filed 2016-03-03 |
| 2015-11-05 | 26.31M shares 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |